Follow-up of Patient Implanted With the Staple ASTUS®
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01518543|
Recruitment Status : Terminated
First Posted : January 26, 2012
Last Update Posted : September 11, 2014
There are many ways of performing arthrodesis in the foot and ankle. Dowel fusion is one of them.
The in situ technique was first described by Ottolenghi et al. (1970) and was taken up by Baciu and Filibiu (1979). In the technique, they did take the dowel out before turning it. The healing process takes place between surfaces of spongious bone. They showed excellent results with early weight bearing and healing within 12.5 weeks. Stranks et al. (1994) combined the dowel technique with screw fixation and claimed 95 % healing rate within 12.5 weeks. Others have not found this technique satisfactory in rheumatoid arthritis patients (Belt et al. 2001). The results were not compatible to common fusion techniques. The reason may be the circular bone gap of at least 1 mm left by the saw blade.
A new instrumentation and a new staple with a central wedge (ASTUS) avoid this gap and allow the dowel to be turned in situ without leaving in position. The staple is introduced into the joint line and will compress the dowel surfaces against the surrounding bone. Instruments are available to ensure the correct position and length of the dowel, and to rotate it in situ before the special wedge staple is introduced.
Dr Kofoed, the surgeon designer of the ASTUS Staple, has communicated on his first series with 83 arthrodesis. The purpose of this study is now to collect and publish data from several centers, several users.
The objective of this study is to obtain the percentage of healing 3 months after an implantation of the staple ASTUS.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||5 participants|
|Official Title:||Follow-up of Patient Implanted With the Staple ASTUS®|
|Study Start Date :||April 2010|
|Actual Primary Completion Date :||January 2012|
|Actual Study Completion Date :||January 2013|
Patient candidate for an arthrodesis in the following joints:Ankle,1st MTP, Metatarso - Cuneiform (1st), Navicular - Cuneiform, Talo-Navicular, Calcaneum - Cuboid, and whose surgeon has recommended the implantation of an ASTUS Staple from Newdeal-INTEGRA.
- Rate of healing at 3 month [ Time Frame: 3 month post implantation ]
- Complications rate [ Time Frame: 12 month follow-up ]Number of patients with an adverse event related to the device
- Length of the surgery [ Time Frame: The time is the day of the surgery, the day the implantation of the device is done ]We collect the information of the length of the surgery for the implantation of the Astus Device
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01518543
|Cappagh National Orthopaedic Hospital|
|Dublin, Ireland, 11|
|Clatterbridge General Hospital|
|Wirral, United Kingdom|